These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 14592911)
1. Standards of measurements in myasthenia gravis. Barohn RJ Ann N Y Acad Sci; 2003 Sep; 998():432-9. PubMed ID: 14592911 [TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Jaretzki A; Barohn RJ; Ernstoff RM; Kaminski HJ; Keesey JC; Penn AS; Sanders DB Ann Thorac Surg; 2000 Jul; 70(1):327-34. PubMed ID: 10921745 [No Abstract] [Full Text] [Related]
4. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Jaretzki A; Barohn RJ; Ernstoff RM; Kaminski HJ; Keesey JC; Penn AS; Sanders DB Neurology; 2000 Jul; 55(1):16-23. PubMed ID: 10891897 [No Abstract] [Full Text] [Related]
5. Standards of measurements in myasthenia gravis. Gajdos P; Sharshar T; Chevret S Ann N Y Acad Sci; 2003 Sep; 998():445-52. PubMed ID: 14592913 [TBL] [Abstract][Full Text] [Related]
6. History of outcome measures for myasthenia gravis. Burns TM Muscle Nerve; 2010 Jul; 42(1):5-13. PubMed ID: 20583125 [TBL] [Abstract][Full Text] [Related]
7. International consensus guidance for management of myasthenia gravis: Executive summary. Sanders DB; Wolfe GI; Benatar M; Evoli A; Gilhus NE; Illa I; Kuntz N; Massey JM; Melms A; Murai H; Nicolle M; Palace J; Richman DP; Verschuuren J; Narayanaswami P Neurology; 2016 Jul; 87(4):419-25. PubMed ID: 27358333 [TBL] [Abstract][Full Text] [Related]
14. Quality of life in 188 patients with myasthenia gravis in China. Yang Y; Zhang M; Guo J; Ma S; Fan L; Wang X; Li C; Guo P; Wang J; Li H; Li Z Int J Neurosci; 2016; 126(5):455-62. PubMed ID: 26000922 [TBL] [Abstract][Full Text] [Related]
15. The best and worst of times in therapy development for myasthenia gravis. Benatar M; Cutter G; Kaminski HJ Muscle Nerve; 2023 Jan; 67(1):12-16. PubMed ID: 36321730 [TBL] [Abstract][Full Text] [Related]
16. Outcome Measures in Myasthenia Gravis: Incorporation Into Clinical Practice. Muppidi S J Clin Neuromuscul Dis; 2017 Mar; 18(3):135-146. PubMed ID: 28221304 [TBL] [Abstract][Full Text] [Related]
18. QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis. Howard JF; Freimer M; O'Brien F; Wang JJ; Collins SR; Kissel JT; Muscle Nerve; 2017 Aug; 56(2):328-330. PubMed ID: 28010051 [TBL] [Abstract][Full Text] [Related]
19. Treatment and clinical research in myasthenia gravis: how far have we come? Barohn RJ Ann N Y Acad Sci; 2008; 1132():225-32. PubMed ID: 18567872 [TBL] [Abstract][Full Text] [Related]
20. Patient-acceptable symptom states in myasthenia gravis. Mendoza M; Tran C; Bril V; Katzberg HD; Barnett C Neurology; 2020 Sep; 95(12):e1617-e1628. PubMed ID: 32759200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]